Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

ViiV Healthcare UK Ltd
Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/10/2011
PIL Telzir Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 08/06/2011 and displayed until 06/10/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 13/05/2011 and displayed until 08/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 31/03/2011 and displayed until 13/05/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 14/09/2010 and displayed until 31/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 05/07/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to Marketing Authorisation Holder
Updated on 20/05/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/01/2010 and displayed until 20/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/06/2009 and displayed until 25/01/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/04/2009 and displayed until 09/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to dosage and administration
Updated on 12/02/2009 and displayed until 01/04/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/02/2009 and displayed until 12/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 08/08/2008 and displayed until 06/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 18/06/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change due to user-testing of patient information
  • Change to drug interactions
  • Change to date of revision
Updated on 02/05/2008 and displayed until 18/06/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 19/01/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change to date of revision
Updated on 23/10/2007 and displayed until 19/01/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to dosage and administration
Updated on 29/03/2007 and displayed until 23/10/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 05/12/2006 and displayed until 29/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 18/05/2006 and displayed until 05/12/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to how to administer the medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
Updated on 27/02/2006 and displayed until 18/05/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 18/11/2004 and displayed until 27/02/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/11/2004 and displayed until 18/11/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  fosamprenavir calcium